Diluted EPS came in at $-0.19, beat the $-0.20 consensus by $0.01.
Trailing eight quarters through Q2 2024
Common questions about NanoViricides's Q2 2024 earnings report.
NanoViricides (NNVC) reported Q2 2024 earnings on September 27, 2024 before market open.
NanoViricides reported diluted EPS of $-0.19 for Q2 2024.
EPS beat the consensus estimate of $-0.20 by $0.01.
You can read the 10-K periodic report (0001410578-24-001650) directly on SEC EDGAR. The filing index links above go to sec.gov.